Lonza Issues License to Antharis Therapeutics for ADCs - CHEManager
Lonza Issues License to Antharis Therapeutics for ADCs CHEManager
Lonza Issues License to Antharis Therapeutics for ADCs CHEManager
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.